Beneficient — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Beneficient filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($7.94M) | Sep 29, 2025 |
| FY2025 | Mar 31, 2024 | ($98.70M) | Sep 29, 2025 |
| FY2024 | Mar 31, 2023 | ($104.90M) | Jul 9, 2024 |
| FY2023 | Mar 31, 2022 | ($66.62M) | Jul 13, 2023 |
| FY2023 | Dec 31, 2021 | $55.31M | Jul 13, 2023 |
| FY2023 | Mar 31, 2021 | $2.36M | Jul 13, 2023 |
| FY2023 | Dec 31, 2020 | $140.33M | Jul 13, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Mar 31, 2024 | ($2.10B) | Jul 9, 2024 |
| FY2024 | Mar 31, 2023 | ($130.98M) | Jul 9, 2024 |
| FY2023 | Mar 31, 2022 | ($44.43M) | Jul 13, 2023 |
| FY2023 | Dec 31, 2021 | ($63.01M) | Jul 13, 2023 |
| FY2023 | Dec 31, 2020 | ($58.04M) | Jul 13, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($24.19M) | Sep 29, 2025 |
| FY2025 | Mar 31, 2024 | ($2.65B) | Sep 29, 2025 |
| FY2024 | Mar 31, 2023 | ($253.17M) | Jul 9, 2024 |
| FY2023 | Mar 31, 2022 | ($99.83M) | Jul 13, 2023 |
| FY2023 | Dec 31, 2021 | ($71.12M) | Jul 13, 2023 |
| FY2023 | Mar 31, 2021 | ($23.24M) | Jul 13, 2023 |
| FY2023 | Dec 31, 2020 | ($47.41M) | Jul 13, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($37.70M) | Sep 29, 2025 |
| FY2025 | Mar 31, 2024 | ($58.22M) | Sep 29, 2025 |
| FY2024 | Mar 31, 2023 | ($95.12M) | Jul 9, 2024 |
| FY2023 | Mar 31, 2022 | ($11.33M) | Jul 13, 2023 |
| FY2023 | Dec 31, 2021 | ($57.00M) | Jul 13, 2023 |
| FY2023 | Mar 31, 2021 | ($17.72M) | Jul 13, 2023 |
| FY2023 | Dec 31, 2020 | ($54.01M) | Jul 13, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.10M | Sep 29, 2025 |
| FY2025 | Mar 31, 2024 | $1.76M | Sep 29, 2025 |
| FY2024 | Mar 31, 2023 | $2.08M | Jul 9, 2024 |
| FY2023 | Mar 31, 2022 | $975.0K | Jul 13, 2023 |
| FY2023 | Dec 31, 2021 | $4.20M | Jul 13, 2023 |
| FY2023 | Mar 31, 2021 | $720.0K | Jul 13, 2023 |
| FY2023 | Dec 31, 2020 | $3.22M | Jul 13, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $354.88M | Sep 29, 2025 |
| FY2025 | Mar 31, 2024 | $368.50M | Sep 29, 2025 |
| FY2024 | Mar 31, 2023 | $2.91B | Jul 9, 2024 |
| FY2023 | Mar 31, 2022 | $3.14B | Jul 13, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $299.27M | Sep 29, 2025 |
| FY2025 | Mar 31, 2024 | $309.57M | Sep 29, 2025 |
| FY2024 | Mar 31, 2023 | $231.79M | Jul 9, 2024 |
| FY2023 | Mar 31, 2022 | $241.43M | Jul 13, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $9.91M | Sep 29, 2025 |
| FY2025 | Mar 31, 2024 | $13.61M | Sep 29, 2025 |
| FY2025 | Mar 31, 2023 | $2.37B | Sep 29, 2025 |
| FY2024 | Mar 31, 2022 | $2.37B | Jul 9, 2024 |
| FY2023 | Dec 31, 2021 | $2.37B | Jul 13, 2023 |
| FY2023 | Dec 31, 2020 | $2.37B | Jul 13, 2023 |
| FY2023 | Dec 31, 2019 | $2.37B | Jul 13, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($2.01B) | Sep 29, 2025 |
| FY2025 | Mar 31, 2024 | ($2.06B) | Sep 29, 2025 |
| FY2024 | Mar 31, 2023 | $0 | Jul 9, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.35M | Sep 29, 2025 |
| FY2025 | Mar 31, 2024 | $7.91M | Sep 29, 2025 |
| FY2024 | Mar 31, 2023 | $8.73M | Jul 9, 2024 |
| FY2023 | Mar 31, 2022 | $70.59M | Jul 13, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | (1) | Jul 13, 2023 |
| FY2023 | Mar 31, 2022 | 0 | Jul 13, 2023 |
| FY2023 | Dec 31, 2021 | (1) | Jul 13, 2023 |
| FY2023 | Mar 31, 2021 | 0 | Jul 13, 2023 |
| FY2023 | Dec 31, 2020 | (1) | Jul 13, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | (1) | Jul 13, 2023 |
| FY2023 | Mar 31, 2022 | 0 | Jul 13, 2023 |
| FY2023 | Dec 31, 2021 | (1) | Jul 13, 2023 |
| FY2023 | Mar 31, 2021 | 0 | Jul 13, 2023 |
| FY2023 | Dec 31, 2020 | (1) | Jul 13, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | 67.49M | Jul 13, 2023 |
| FY2023 | Mar 31, 2022 | 67.49M | Jul 13, 2023 |